BioMarin focuses on developing first-in-class or best in-class therapeutics that provide meaningful advances to patients who live with serious and life-threatening rare genetic diseases. These patient populations suffer from diseases so rare that
they can affect as few as 1,000 people worldwide. The conditions are often inherited, difficult to diagnose, progressively debilitating and have few, if any, treatment options.
Since its foundation in 1997, BioMarin has brought seven products to market, with five more in the pipeline, near a billion dollars of annual revenue and a global footprint in 60+ countries. BioMarin is a recognized industry leader in developing treatments for rare diseases.
Consistent with BioMarin’s origins and a real entrepreneurial thread, it is a dynamic pharmaceutical organization with passionate employees. Patients are at the center of everything BioMarin stands for and we seek out individuals who want to make a difference and improve the lives of patients.
We’re seeking medical and statistical geneticists to develop and lead a new research program at BioMarin Pharmaceutical spearheaded by our CSO Lon Cardon. The candidates will be responsible for an integrated research program involving academic, industry and NHS-aligned research groups in the UK with the aim of translating the unique clinical and population resources and commitment to human genomics research to therapeutic hypotheses. The successful candidates
will have the opportunity to work in a fast-paced and highly collaborative environment of both drug discovery and clinical development in London and San Rafael, CA and will be responsible for developing programs that couple rigorous mechanistic foundations with clear and measurable phenotypic/clinical endpoints.
Interested individuals should reach out to email@example.com referencing ‘Rare Disease Geneticists’ to announce their candidacy.